Summary
The protocol covers diagnosis, treatment, relapse prevention, and rehabilitation across different forms and courses of schizophrenia. The disorder is presented as a combination of positive symptoms—delusions, hallucinations, disorganized thinking, and catatonic phenomena—with negative, cognitive, affective, and behavioral disturbances. Particular attention is given to the first psychotic episode, recurrent exacerbations, continuous illness, and remission.
Diagnosis is based on clinical interviewing, mental-state examination, and information from the patient and close relatives. The assessment reviews onset and progression, prodromal changes, social functioning, psychoactive-substance use, and possible neurological or medical illness. Depressive symptoms, suicidal or aggressive tendencies, and cognitive impairment are also evaluated. Laboratory and instrumental tests do not directly establish schizophrenia; they are used to exclude organic, neurological, medical, and substance-related causes of psychosis and to support safe treatment planning.
Antipsychotic medication is the core intervention during acute, stabilization, and maintenance phases. Selection is individualized according to prior response, tolerability, comorbidity, adverse-effect risk, formulation, and treatment adherence, with a separate pathway for treatment-resistant illness. Medication is complemented by patient and family psychoeducation, cognitive behavioral therapy, cognitive remediation, social-skills training, and support for everyday, educational, and vocational functioning. The overall objectives are sustained remission, relapse reduction, improved social functioning, and better quality of life. This text summarizes the protocol and is not a substitute for an individual assessment or treatment recommendation from a qualified professional.